Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

936 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer.
Salaroglio IC, Belisario DC, Akman M, La Vecchia S, Godel M, Anobile DP, Ortone G, Digiovanni S, Fontana S, Costamagna C, Rubinstein M, Kopecka J, Riganti C. Salaroglio IC, et al. Among authors: rubinstein m. J Exp Clin Cancer Res. 2022 Aug 11;41(1):243. doi: 10.1186/s13046-022-02447-6. J Exp Clin Cancer Res. 2022. PMID: 35953814 Free PMC article.
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer.
Salaroglio IC, Gazzano E, Abdullrahman A, Mungo E, Castella B, Abd-Elrahman GEFA, Massaia M, Donadelli M, Rubinstein M, Riganti C, Kopecka J. Salaroglio IC, et al. Among authors: rubinstein m. J Exp Clin Cancer Res. 2018 Nov 27;37(1):286. doi: 10.1186/s13046-018-0967-0. J Exp Clin Cancer Res. 2018. PMID: 30482226 Free PMC article.
The role of C/EBP-β LIP in multidrug resistance.
Riganti C, Kopecka J, Panada E, Barak S, Rubinstein M. Riganti C, et al. Among authors: rubinstein m. J Natl Cancer Inst. 2015 Mar 11;107(5):djv046. doi: 10.1093/jnci/djv046. J Natl Cancer Inst. 2015. PMID: 25766403
Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma.
Kopecka J, Salaroglio IC, Righi L, Libener R, Orecchia S, Grosso F, Milosevic V, Ananthanarayanan P, Ricci L, Capelletto E, Pradotto M, Napoli F, Di Maio M, Novello S, Rubinstein M, Scagliotti GV, Riganti C. Kopecka J, et al. Among authors: rubinstein m. Lung Cancer. 2018 Jun;120:34-45. doi: 10.1016/j.lungcan.2018.03.022. Epub 2018 Mar 26. Lung Cancer. 2018. PMID: 29748013 Free article.
C/EBPβ LIP augments cell death by inducing osteoglycin.
Wassermann-Dozorets R, Rubinstein M. Wassermann-Dozorets R, et al. Among authors: rubinstein m. Cell Death Dis. 2017 Apr 6;8(4):e2733. doi: 10.1038/cddis.2017.155. Cell Death Dis. 2017. PMID: 28383550 Free PMC article.
Leukotrienes and kidney diseases.
Rubinstein M, Dvash E. Rubinstein M, et al. Curr Opin Nephrol Hypertens. 2018 Jan;27(1):42-48. doi: 10.1097/MNH.0000000000000381. Curr Opin Nephrol Hypertens. 2018. PMID: 29059080 Free PMC article. Review.
A surprising mediator of oxidative DNA damage.
Dvash E, Rubinstein M. Dvash E, et al. Among authors: rubinstein m. Cell Cycle. 2016;15(7):869-70. doi: 10.1080/15384101.2016.1144989. Epub 2016 Feb 18. Cell Cycle. 2016. PMID: 26890977 Free PMC article. No abstract available.
936 results